CSIMarket


Cryo cell International Inc  (CCEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cryo Cell International Inc's Working Capital Ratio

CCEL's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




CCEL Working Capital Ratio (Aug 31 2021)
III. Quarter
(May 31 2021)
II. Quarter
(Feb 28 2021)
I. Quarter
(Aug 31 2020)
III. Quarter
(May 31 2020)
II. Quarter
Y / Y Current Liabilities Change 31.52 % 25.2 % 355.35 % 163.01 % 196.4 %
Y / Y Current Assets Change -13.65 % -12.5 % 21.5 % 5.3 % 15.18 %
Working Capital Ratio MRQ 0.75 0.73 0.63 1.16 1.14
Overall Ranking # # # # #
Seq. Current Liabilities Change -1.3 % -32.59 % 106.86 % -4.44 % -6.05 %
Seq. Current Assets Change 0.93 % -20.93 % 11.53 % -2.99 % 2.28 %



Working Capital Ratio third quarter 2021 Comment
Cryo Cell International Inc's Current Assets grew by 0.93 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Cryo Cell International Inc's Working Capital Ratio to 0.75, Working Capital Ratio remained below Cryo cell International Inc average.

Within Medical Laboratories industry 50 other companies have achieved higher Working Capital Ratio than Cryo Cell International Inc in third quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is CCEL most successful ?
Working Capital Ratio CCEL on the trailing twelve month basis
Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Medical Laboratories Industry # 51
Healthcare Sector # 950
Overall Market # 4603


Working Capital Ratio Statistics
High Average Low
4.33 1.25 0.63
(Feb 28 2019)   (Feb 28 2021)




Financial Statements
Cryo Cell International Inc's Current Liabilities $ 20 Millions Visit CCEL's Balance sheet
Cryo Cell International Inc's Current Assets $ 15 Millions Visit CCEL's Balance sheet
Source of CCEL's Sales Visit CCEL's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingAug 31 2021, within Medical Laboratories Industry Working Capital RatioAug 31 2021 MRQ Current AssetsAug 31 2021 MRQ Current Liabilities
Eventbrite Inc   1.90 $ 712.919  Millions$ 374.297  Millions
National Research Corporation  1.86 $ 72.726  Millions$ 39.170  Millions
Charles River Laboratories International inc   1.81 $ 1,379.040  Millions$ 762.020  Millions
Quest Diagnostics Inc  1.77 $ 2,854.000  Millions$ 1,611.000  Millions
Opgen Inc   1.55 $ 29.780  Millions$ 19.167  Millions
Iqvia Holdings Inc   1.50 $ 4,534.000  Millions$ 3,021.000  Millions
Progenity Inc   1.49 $ 92.970  Millions$ 62.313  Millions
Radnet Inc   1.27 $ 381.246  Millions$ 300.882  Millions
Ppd Inc   1.23 $ 3,429.067  Millions$ 2,798.561  Millions
Sorrento Therapeutics Inc   1.15 $ 200.720  Millions$ 175.184  Millions
Syneos Health Inc   1.04 $ 1,764.199  Millions$ 1,688.271  Millions
Cryo cell International Inc  0.75 $ 14.921  Millions$ 19.858  Millions
International Stem Cell Corporation  0.57 $ 2.486  Millions$ 4.349  Millions
Healthcor Catalio Acquisition Corp   0.48 $ 0.928  Millions$ 1.946  Millions
Science 37 Holdings Inc   0.40 $ 0.289  Millions$ 0.715  Millions
Kraig Biocraft Laboratories Inc   0.30 $ 2.706  Millions$ 9.045  Millions
United Health Products Inc   0.21 $ 0.228  Millions$ 1.073  Millions
Grapefruit Usa Inc   0.18 $ 0.848  Millions$ 4.786  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RSKIA's Profile

Stock Price

RSKIA's Financials

Business Description

Fundamentals

Charts & Quotes

RSKIA's News

Suppliers

RSKIA's Competitors

Customers & Markets

Economic Indicators

RSKIA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071